How long after use can cocaine and methamphetamine be detected in a standard laboratory urine drug screen?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Detection Windows for Cocaine and Methamphetamine in Urine Drug Screens

Cocaine can be detected in urine for approximately 1.5 to 4 days after a single use, while methamphetamine remains detectable for 2 to 5 days, with both detection windows extending significantly in chronic users.

Detection Times by Drug

Cocaine

  • Single use: 1.5-4 days at standard cutoffs (300 ng/mL for benzoylecgonine) 1, 2
  • Chronic use: Up to 1 week after last use 1
  • The primary metabolite tested is benzoylecgonine, which has a longer detection window than parent cocaine 3
  • Detection can be extended by lowering cutoff concentrations—reducing from 300 ng/mL to 50 ng/mL can increase detection time by up to 55% 3

Methamphetamine

  • Single use: 2-5 days at standard cutoffs (500 ng/mL for methamphetamine, 200 ng/mL for amphetamine) 4, 2
  • Chronic use: Approximately 1 week after last use 1
  • The biological half-life is 4-5 hours, but approximately 62% of an oral dose is eliminated in urine within the first 24 hours 5
  • The mean urinary terminal elimination half-life is 23.6 hours for methamphetamine and 20.7 hours for amphetamine 6
  • Lowering cutoffs to 250/100 ng/mL extends terminal detection by up to 24 hours and increases total detection time by up to 34 hours 4

Critical Factors Affecting Detection

Urine pH Dependency

Urine pH dramatically affects detection windows for both drugs. Alkaline urine significantly increases methamphetamine's half-life, while acidic urine shortens it 5. This pH-dependent excretion creates substantial interindividual variability in detection times 6, 7.

Dose and Frequency

  • Higher doses and chronic use extend detection windows considerably
  • Methamphetamine shows drug accumulation with repeated dosing due to slow urinary excretion 6
  • Street doses of cocaine are detectable up to 1 week, with extremely high doses detectable up to 3 weeks 2

Route of Administration

  • Different routes (intravenous, smoking, intranasal) produce varying elimination half-lives
  • Elimination half-lives are generally shorter following smoking, intermediate after intravenous, and longest following intranasal administration 3

Clinical Pitfalls

Common causes of false-negative results:

  • Dilute urine specimens that fall below cutoff thresholds
  • Testing too early (before drug reaches detectable urinary concentrations) or too late (after elimination)
  • pH manipulation—alkalinizing agents increase blood levels and decrease urinary excretion of amphetamines 5

Important considerations:

  • Standard immunoassay cutoffs (300 ng/mL) may miss positive specimens that would be detected at lower thresholds 3
  • Methamphetamine requires both parent drug AND amphetamine metabolite confirmation at specific thresholds (≥500 and ≥200 µg/L respectively) 4
  • Urine testing provides a longer detection window than blood (2-12 hours) or saliva (24-48 hours) 8

Practical Detection Windows

For typical laboratory urine drug screens using standard cutoffs:

  • Cocaine (single use): 2-3 days reliably, up to 4 days possible
  • Methamphetamine (single use): 2-4 days reliably, up to 5 days possible
  • Both drugs (chronic use): Approximately 1 week, occasionally longer

These windows assume normal urine pH, adequate hydration, and standard immunoassay cutoffs followed by confirmatory testing 1, 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.